Medical device inventory software is a small market with a handful of serious players and a long tail of ERP modules and spreadsheet workarounds. As of early 2026, these are the platforms most frequently evaluated by orthopedic, spine, and trauma teams:

The mid-market gap

The dedicated platforms in this space — Movemedical, ImplantBase, WebOps — were architected for enterprise manufacturers and large OEMs. Six-figure annual commitments, multi-month implementations, dedicated IT teams on both sides. That leaves a specific gap: companies doing $20M–$200M in revenue, running 200–2,000 cases per month, with ops teams of 3–15 people. Too big for spreadsheets, too small for enterprise software.

These mid-market teams don’t need another system to manage inventory data — they need help getting data into a manageable state in the first place. The expensive problem isn’t tracking what’s in the field. It’s the investigation loop that precedes every transaction: reading the charge sheet, matching the pricing, reconciling against the contract, and typing the result into the ERP. That’s where 80% of processing time goes — and none of the platforms on the next page were built to eliminate it.

What changed in the last ten months

Three regulatory events pulled operations software into validated-system scope. July 2025: ISPE GAMP AI Guide. September 2025: FDA finalized Computer Software Assurance, AI/ML in scope. February 2, 2026: QMSR harmonized 21 CFR Part 820 with ISO 13485:2016. Charge sheet capture, PO matching, consignment tracking — anything that touches a record contributing to device release now carries Part 11 expectations, plus AI-specific overlays. Question for the buyer: does this vendor reduce your validation burden, or transfer it?

These are the platforms most frequently evaluated by orthopedic, spine, and trauma teams as of early 2026. Each serves a different buyer profile — the right choice depends on your scale, ERP environment, and where your operational pain actually lives.

Movemedical

The broadest platform in the space — 14 million+ surgeries across 20+ ERP integrations since 2014. Scheduling, ordering, picking, packing, shipping, usage capture, billing, transfers, replenishment, audit. Billing is included, but data must be entered manually; Movemedical doesn’t read inbound emails or PO attachments. Architected for organizations 5–10× the size of most mid-market buyers.

ImplantBase (Surgimate)

Started in orthopedic field inventory. Granular tracking — piece-level by lot, serial, expiration across consignment, loaner, and trunk stock. Surgimate integration closes the hospital-to- manufacturer loop, but its install base is small enough that closed-loop applies to a handful of accounts. Thinner on ERP depth and billing automation.

WebOps

Enterprise-first. Integrates with SAP, Oracle, NetSuite, QAD, SysPro. Built for multi-region OEMs with dedicated IT teams. Lists billing automation, but data must be entered manually — no email integration, no inbound document processing. Aged UI; analytics carry additional cost.

ERP-native modules

Handle basic inventory transactions but lack field workflows. The deeper problem is access: field-user ERP licenses are expensive (SAP/NetSuite) or require loosening security posture for external users. Most companies decide it’s not worth it — the ERP stays locked to the back office and everyone else works out of email and text threads.

Evaluated by the criteria that matter during implementation, not just during a demo.

QMSR pulled operations software into validated-system scope on February 2, 2026. The audit consequence: any tool that captures charge sheets, matches POs, tracks consignment, or feeds a record contributing to device release now needs the same documentation posture the QMS software side has carried for years.

For buyers, validation posture is now part of the evaluation. The right vendor reduces your validation burden. The wrong vendor increases it.

The GAMP category determines who carries the work

• Category 3 — non-configured commercial software. Vendor carries the lifecycle; you document intended use.
• Category 4 — configured commercial software. Vendor carries design controls, verification, release management, vendor audits. You configure and validate use. The category that protects your team most.
• Category 5 — custom-developed software. In-house code, AI-assisted prototypes, significantly modified open-source. The vendor of your software is you. 50–100% more validation effort than Category 4.

Building it yourself looks cheaper until you price in the lifecycle. Then it’s the most expensive software you own.

AI changes the question, not the answer

The July 2025 ISPE GAMP AI Guide and the September 2025 FDA CSA finalization closed the gap that had let AI-enabled software sit in a gray zone. The buyer’s question shifts: not “does this vendor have AI?” but “has the AI been validated, with documented oversight, drift monitoring, and rollback?” A vendor running AI-driven extraction or routing without those artifacts is shipping a regulatory exposure dressed up as a feature.

What you still own as the buyer

A Category 4 vendor reduces your work, not your work. Your team still owns: a URS for the system in your context, configuration documentation, validation of intended use, training records, periodic vendor audits (ISO 13485 Clause 7.4), and change control for your configuration changes. Materially less than building it yourself — not zero.

A vendor that takes validation seriously will be able to answer these without flinching. A vendor that doesn’t will redirect to marketing collateral.

Feature matrices don’t differentiate platforms. These questions do — because the answers expose what happens after the demo.

Every platform in this space now claims AI or machine learning capabilities. That’s made evaluation harder, not easier, because the label covers an enormous range — from a recommendation engine that suggests reorder quantities to a system that actually reads an email, extracts a purchase order, matches it against a contract, and pushes a clean record into your ERP without anyone touching it.

The question isn’t whether a platform uses AI. It’s whether the AI does work, or whether it just presents information slightly differently while your team still logs into the application, reviews every record, and manually processes every transaction.

When a vendor says “AI-powered,” ask: what specific work does a person no longer have to do? Not “what can the AI help with” — what does it actually complete, end to end, without a person in the middle?

Print this page and bring it to your next demo. Check each item as you confirm it with the vendor.